Loading clinical trials...
Loading clinical trials...
A Phase 2 Clinical Trial to Assess the Safety and Observe the Potential Benefit of TTHX1114 Delivered Via Intra-Cameral (IC) Injection
Conditions
Interventions
TTHX1114
Locations
2
United States
Trefoil Study Site
Atlanta, Georgia, United States
Trefoil Study Site
Washington, Missouri, United States
Start Date
November 30, 2021
Primary Completion Date
August 29, 2023
Completion Date
October 31, 2023
Last Updated
November 7, 2023
NCT00744796
NCT04191629
Lead Sponsor
Trefoil Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions